NCT07515859 2026-04-13
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
Completed
Clinical Trials
16 trialsNCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
NCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT02696707 2025-12-18
OTT 15-05
Ottawa Hospital Research Institute
Phase 4 Completed
NCT07267247 2025-12-05
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Completed
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04790266 2025-11-18
CARDIOTOX
Oncology Institute of Southern Switzerland
Completed
NCT04036032 2025-10-14
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
Completed
NCT04023110 2025-10-09
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT06888505 2025-09-18
DAPA-AIC
Hawler Medical University
Phase 2 Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed